Skip to main content

Journal of Nanobiotechnology's Collection

Women in Nanobiotechnology

New Content ItemGuest Editors: Dr Zi (Sophia) Gu (University of New South Wales, Australia),  Dr Wei Tao (Harvard Medical School, USA).

Journal of Nanobiotechnology invites submissions to a collection on Women in Nanobiotechnology.

We are proud to announce the inaugural collection featuring Women in Nanobiotechnology (WiN). Women researchers have made enormous contributions to knowledge advancement in the field of nanobiotechnology. However, it has been noted that the STEM fields, including nanobiotechnology, have remained predominantly male with low participation of women. The WiN collection aims to highlight female researchers’ achievements and their significant contributions to the nanobiotechnology field, and to encourage more women to participate in science and technology, towards gender equity and equality in the scientific community. Taking the WiN as a starting point, we hope to create a progressive, inclusive environment that encourages more women in nanobiotechnology research to lead and excel.

Submissions of original Research Article and Review papers, having corresponding authors who are women, are invited to this ongoing collection. Please submit via journal online submission system and indicate at the Additional Information stage of submission that you are submitting to the Women in Nanobiotechnology collection. All manuscripts received will be subject to editorial triage and peer review as is standard for the journal.

Articles will be published continuously in the main journal and highlighted on the collection homepage as soon as they are ready.

  1. Although combination chemoimmunotherapy shows promising clinical results for cancer treatment, this approach is largely restricted by variable objective response rate and severe systemic adverse effects of imm...

    Authors: Jun Gu, Gang Zhao, Jiangkun Yu, Pei Xu, Jiabin Yan, Zhengshuai Jin, Sheng Chen, Yong Wang, Leshuai W. Zhang and Yangyun Wang
    Citation: Journal of Nanobiotechnology 2022 20:372
  2. The failure of orthopedic and dental implants is mainly caused by biomaterial-associated infections and poor osseointegration. Surface modification of biomedical materials plays a significant role in enhancing...

    Authors: Libin Lu, Jiaru Zhang, Kai Guan, Jin Zhou, Fusong Yuan and Yingchun Guan
    Citation: Journal of Nanobiotechnology 2022 20:365
  3. The conversion of tumor-promoting M2 macrophage phenotype to tumor-suppressing M1 macrophages is a promising therapeutic approach for cancer treatment. However, the tumor normally provides an abundance of M2 m...

    Authors: Yongmei Zhao, Yuanlin Zheng, Yan Zhu, Hongyun Li, Hongyan Zhu and Tianqing Liu
    Citation: Journal of Nanobiotechnology 2022 20:359
  4. In this study, we used the nanoparticle delivery system to reduce the side effect of conventional cancer treatment- radiation therapy and chemotherapy. We used rice husk silicon source mesoporous silica nanopa...

    Authors: Zui-Harng Lee, Meng-Feng Lee, Jung-Huang Chen, Min-Hsuan Tsou, Zhi-Yuan Wu, Cheng-Zhang Lee, Yu-Ya Huang, Showe-Mei Lin and Hsiu-Mei Lin
    Citation: Journal of Nanobiotechnology 2022 20:298
  5. Two-dimensional ultrathin Ti3C2 (MXene) nanosheets have been extensively explored for various biomedical applications. However, safety issues and the effects of Ti3C2 on human health remain poorly understood.

    Authors: Yixian Wen, Le Hu, Jian Li, Yanqing Geng, Yang Yang, Jing Wang, Xuemei Chen, Liliang Yu, Hongyu Tang, Tingli Han, Yongxiu Yang and Xueqing Liu
    Citation: Journal of Nanobiotechnology 2022 20:108